589 related articles for article (PubMed ID: 21482091)
1. Improved respiratory system conductance following bronchodilator predicts reduced exertional dyspnoea.
Diba C; King GG; Berend N; Salome CM
Respir Med; 2011 Sep; 105(9):1345-51. PubMed ID: 21482091
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of acute bronchodilator reversibility in patients with symptoms of GOLD stage I COPD.
O'Donnell DE; Laveneziana P; Ora J; Webb KA; Lam YM; Ofir D
Thorax; 2009 Mar; 64(3):216-23. PubMed ID: 19052054
[TBL] [Abstract][Full Text] [Related]
3. Modulation of operational lung volumes with the use of salbutamol in COPD patients accomplishing upper limbs exercise tests.
Porto EF; Castro AA; Nascimento O; Oliveira RC; Cardoso F; Jardim JR
Respir Med; 2009 Feb; 103(2):251-7. PubMed ID: 18930646
[TBL] [Abstract][Full Text] [Related]
4. Acute effects of indacaterol on lung hyperinflation in moderate COPD: a comparison with tiotropium.
Rossi A; Centanni S; Cerveri I; Gulotta C; Foresi A; Cazzola M; Brusasco V
Respir Med; 2012 Jan; 106(1):84-90. PubMed ID: 22035851
[TBL] [Abstract][Full Text] [Related]
5. Bronchodilator responsiveness in patients with COPD.
Tashkin DP; Celli B; Decramer M; Liu D; Burkhart D; Cassino C; Kesten S
Eur Respir J; 2008 Apr; 31(4):742-50. PubMed ID: 18256071
[TBL] [Abstract][Full Text] [Related]
6. The effect of tiotropium on hyperinflation and exercise capacity in chronic obstructive pulmonary disease.
Verkindre C; Bart F; Aguilaniu B; Fortin F; Guérin JC; Le Merre C; Iacono P; Huchon G
Respiration; 2006; 73(4):420-7. PubMed ID: 16484769
[TBL] [Abstract][Full Text] [Related]
7. Superiority of "triple" therapy with salmeterol/fluticasone propionate and tiotropium bromide versus individual components in moderate to severe COPD.
Singh D; Brooks J; Hagan G; Cahn A; O'Connor BJ
Thorax; 2008 Jul; 63(7):592-8. PubMed ID: 18245142
[TBL] [Abstract][Full Text] [Related]
8. Tiotropium administered by a pressurized metered dose inhaler (pMDI) and spacer produces a similar bronchodilator response as that administered by a Rotahaler in adult subjects with stable moderate-to-severe COPD.
Brashier B; Dhembare P; Jantikar A; Mahadik P; Gokhale P; Gogtay JA; Salvi SS
Respir Med; 2007 Dec; 101(12):2464-71. PubMed ID: 17719763
[TBL] [Abstract][Full Text] [Related]
9. Reversibility of inspiratory lung function parameters after short-term bronchodilators in COPD.
Ramlal SK; Visser FJ; Hop WC; Dekhuijzen PN; Heijdra YF
Respir Physiol Neurobiol; 2010 Aug; 173(1):58-63. PubMed ID: 20601207
[TBL] [Abstract][Full Text] [Related]
10. Mechanisms of dyspnoea relief and improved exercise endurance after furosemide inhalation in COPD.
Jensen D; Amjadi K; Harris-McAllister V; Webb KA; O'Donnell DE
Thorax; 2008 Jul; 63(7):606-13. PubMed ID: 18250181
[TBL] [Abstract][Full Text] [Related]
11. Effect of tiotropium bromide on the cardiovascular response to exercise in COPD.
Travers J; Laveneziana P; Webb KA; Kesten S; O'Donnell DE
Respir Med; 2007 Sep; 101(9):2017-24. PubMed ID: 17475459
[TBL] [Abstract][Full Text] [Related]
12. Additive benefits of tiotropium in COPD patients treated with long-acting beta agonists and corticosteroids.
Perng DW; Wu CC; Su KC; Lee YC; Perng RP; Tao CW
Respirology; 2006 Sep; 11(5):598-602. PubMed ID: 16916333
[TBL] [Abstract][Full Text] [Related]
13. Changes in lung function and health status in patients with COPD treated with tiotropium or salmeterol plus fluticasone.
Kurashima K; Hara K; Yoneda K; Kanauchi T; Kagiyama N; Tokunaga D; Takayanagi N; Ubukata M; Sugita Y
Respirology; 2009 Mar; 14(2):239-44. PubMed ID: 19210650
[TBL] [Abstract][Full Text] [Related]
14. Benefits of adding fluticasone propionate/salmeterol to tiotropium in moderate to severe COPD.
Hanania NA; Crater GD; Morris AN; Emmett AH; O'Dell DM; Niewoehner DE
Respir Med; 2012 Jan; 106(1):91-101. PubMed ID: 22040533
[TBL] [Abstract][Full Text] [Related]
15. Effect of adjunct fluticasone propionate on airway physiology during rest and exercise in COPD.
Guenette JA; Raghavan N; Harris-McAllister V; Preston ME; Webb KA; O'Donnell DE
Respir Med; 2011 Dec; 105(12):1836-45. PubMed ID: 21917440
[TBL] [Abstract][Full Text] [Related]
16. Inhaled corticosteroids as additional treatment in alpha-1-antitrypsin-deficiency-related COPD.
Corda L; Bertella E; La Piana GE; Boni E; Redolfi S; Tantucci C
Respiration; 2008; 76(1):61-8. PubMed ID: 18319586
[TBL] [Abstract][Full Text] [Related]
17. Effects of tiotropium or combined therapy with salmeterol on hyperinflation in COPD.
Eguchi Y; Tateishi Y; Umeda N; Yoshikawa T; Kamoi H; Kanazawa H; Kudoh S; Hirata K; Fujimoto S
Osaka City Med J; 2007 Jun; 53(1):25-34. PubMed ID: 17867631
[TBL] [Abstract][Full Text] [Related]
18. Tiotropium and simplified detection of dynamic hyperinflation.
Gelb AF; Taylor CF; McClean PA; Shinar CM; Rodrigues MT; Gutierrez CA; Chapman KR; Zamel N
Chest; 2007 Mar; 131(3):690-695. PubMed ID: 17356081
[TBL] [Abstract][Full Text] [Related]
19. Sensory-mechanical relationships during high-intensity, constant-work-rate exercise in COPD.
O'Donnell DE; Hamilton AL; Webb KA
J Appl Physiol (1985); 2006 Oct; 101(4):1025-35. PubMed ID: 16675610
[TBL] [Abstract][Full Text] [Related]
20. Effects of tiotropium on lung hyperinflation, dyspnoea and exercise tolerance in COPD.
O'Donnell DE; Flüge T; Gerken F; Hamilton A; Webb K; Aguilaniu B; Make B; Magnussen H
Eur Respir J; 2004 Jun; 23(6):832-40. PubMed ID: 15218994
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]